-

Sheridan Capital Partners Announces Sale of Dermatologists of Central States

CHICAGO--(BUSINESS WIRE)--Sheridan Capital Partners (“Sheridan”) is pleased to announce the sale of Dermatologists of Central States (“DOCS” or the “the Company”) to SkyKnight Capital (“SkyKnight”). Headquartered in Cincinnati and with a presence in seven states, DOCS is differentiated provider of management services to dermatology practices in the Midwest and Southeast United States.

“I want to thank Sheridan for their knowledge and support in building a scaled patient-centric organization,” said John Macke, Chief Executive Officer of DOCS. “We are proud of the culture and reputation we established and are excited to replicate our model and philosophy throughout the country during our next phase of growth.”

During Sheridan’s ownership, DOCS scaled from 18 locations in Ohio and 41 providers to over 80 locations and 190 providers nationally.

“The entire corporate team and the physicians have been exceptional partners,” said Jonathan Lewis of Sheridan Capital Partners. “From the outset, we aligned in our focus on patient care and serving our providers.”

Sean Dempsey of Sheridan Capital Partners added, “John and the entire team at DOCS have built a tremendous company whose clinical reputation enabled us to grow from a single state to one of the largest dermatology group practices in the US.”

McGuireWoods LLP served as legal advisor to Sheridan. Harris Williams served as exclusive financial advisor to the Company. Holland & Knight LLP served as legal advisor to SkyKnight Capital. Antares Capital LP led the debt syndication for the transaction.

The transaction was led by Jonathan Lewis, Sean Dempsey, Christopher McCrory, and Matthew Meyers at Sheridan Capital Partners. Terms of the transaction were not disclosed.

About Sheridan Capital Partners

Sheridan Capital Partners is a Chicago-based healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada. Sheridan partners with companies in the verticals of providers and provider services, healthcare IT and outsourced services, and consumer health and medical products, bringing strategic resources to accelerate growth, build enduring value, and achieve strong results.

For more information, please visit www.sheridancp.com.

Contacts

Alexandra Kier
Sheridan Capital Partners
Alexandra.Kier@sheridancp.com
312-273-5353

Sheridan Capital Partners


Release Versions

Contacts

Alexandra Kier
Sheridan Capital Partners
Alexandra.Kier@sheridancp.com
312-273-5353

More News From Sheridan Capital Partners

Sheridan Capital Partners Announces Majority Sale of DAS Health

CHICAGO--(BUSINESS WIRE)--Sheridan Capital Partners (“Sheridan”) today announced the majority sale of DAS Health Ventures, LLC (“DAS Health” or “the Company”), a provider of healthcare IT and business solutions, to Coalesce Capital. Sheridan initially partnered with DAS Health in 2021 and will retain a minority ownership position following the transaction. Founded in 2003 by David Schlaifer and headquartered in Tampa, FL, DAS Health provides managed IT services, cybersecurity, cloud hosting, re...

Sheridan Capital Partners-Backed Future Care Consultants Rebrands to Focal Point Care

CHICAGO--(BUSINESS WIRE)--Sheridan Capital Partners (“SCP”) partnered with Future Care Consultants (“FCC”, now branded as Focal Point Care “FPC”), a specialty revenue cycle management and technology-enabled back-office outsourced services provider to the skilled nursing facility (“SNF”) market, in January 2023. Over the past two years, the company has undergone rapid transformation, evolving into a provider of end-to-end solutions for skilled nursing facilities and offering critical support to...

Sheridan Capital Partners-Backed Oral Surgery Partners Announces Appointment of New CEO

CHICAGO--(BUSINESS WIRE)--Oral Surgery Partners (“OSP”), an established oral surgery management group, is pleased to announce the appointment of Sohail Malad as its new Chief Executive Officer, effective August 12th. Sohail Malad, a seasoned healthcare executive with a proven track record of leadership and innovation, will succeed John Cline, who served as CEO for the past three years and will continue to remain involved in an advisory capacity. Under John’s tenure, OSP experienced significant...
Back to Newsroom